Scott Halpern, MD, PhD, is a professor of medicine, epidemiology, and medical ethics and health policy at the University of Pennsylvania where he is also a practicing palliative care doctor. He is the founding director of the Palliative and Advanced Illness Research (PAIR) Center, which unites more than 70 team members around the goals of developing and testing interventions to improve the value and equity of health care delivery for patients affected by serious illnesses, including dementia. He has led more than 35 RCTs testing interventions to change clinicians' and patients' health-related behaviors, most of which have had highly pragmatic orientations. His contributions to science and biomedical ethics have been recognized with election to ASCI, AAP, the National Academy of Medicine and the Hastings Center. His proudest accomplishments, however, relate to his track record of mentorship, which has been recognized with many awards and led to more than 20 trainees becoming faculty members and patient-oriented researchers at top academic medical centers.

Kristin Harkins, MPH, serves as project manager and core navigator for the NIA IMPACT Collaboratory’s Ethics and Regulation Core. Kristin has extensive experience executing the day to day operations of research on ethical and social issues in late life cognitive impairment, and in the design and implementation of quantitative and qualitative studies. As research program manager, Kristin oversees the research and administrative activities of the Penn Program on Precision Medicine for the Brain (P3MB).

Spencer Hey, PhD, is the co-founder and chief scientific officer of Prism Analytic Technologies, a data and analytics software company. Prior to founding Prism, he was a faculty member at the Harvard Medical School. He received his doctorate in philosophy from the University of Western Ontario and previously held a postdoctoral fellowship in the biomedical ethics unit at McGill University and a visiting scholarship at Oxford University. Dr. Hey’s research interests lie at the intersection of biomedical ethics and philosophy of science—with a focus on clinical trials and the ethical challenges that arise across the drug research and development enterprise. His published work has appeared in scientific, medical, bioethics, and philosophical venues, including Science Magazine, JAMA Internal Medicine, Neurology, The BMJ, PLoS Medicine, Journal of Medical Ethics, Hastings Center Report, Perspectives in Biology and Medicine, and Philosophy of Science.

Kimberly Cheng Hom, MPA, is the program officer for the NIA IMPACT Collaboratory Research Grants Core. Prior to her role with the Collaboratory, Ms. Hom’s work focused on building and strengthening the interprofessional workforce through online learning and community-based programs to better care for the needs of the older adult population. Specifically focusing on resources for healthcare professionals that build their capacity in topics such as Alzheimer’s disease and related dementias. Ms. Hom received her master’s degree in public administration from the NYU Wagner Graduate School of Public Service.